These results also should suggest reducing the length of the fasting period before any procedural or surgical intervention in hospitalized T2DM patients; additionally, a diet richer in carbohydrates should be implemented in these patients, especially in those with SGLT2 inhibitors, which can potentially increase 3BOHB reabsorption [5]. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.